Agency Forms Undergoing Paperwork Reduction Act Review, 58513-58514 [2016-20366]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 165 / Thursday, August 25, 2016 / Notices
Centers for Disease Control and
Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-16–0852]
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Prevalence Survey of HealthcareAssociated Infections (HAIs) and
Antimicrobial Use in U.S. Acute Care
Hospitals (OMB Control No. 0920–0852,
Expires 12/31/2016)—Revision—
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
VerDate Sep<11>2014
19:30 Aug 24, 2016
Jkt 238001
Background and Brief Description
Preventing healthcare-associated
infections (HAIs) and reducing the
emergence and spread of antimicrobial
resistance are priorities for the CDC and
the U.S. Department of Health and
Human Services (DHHS). Improving
antimicrobial drug prescribing in the
United States is a critical component of
strategies to reduce antimicrobial
resistance, and is a key component of
the President’s National Strategy for
Combating Antibiotic Resistant Bacteria
(CARB), which calls for ‘‘inappropriate
inpatient antibiotic use for monitored
conditions/agents’’ to be ‘‘reduced 20%
from 2014 levels’’ (page 9, https://
www.whitehouse.gov/sites/default/files/
docs/carb_national_strategy.pdf). To
achieve these goals and improve patient
safety in the United States, it is
necessary to know the current burden of
infections and antimicrobial drug use in
different healthcare settings, including
the types of infections and drugs used
in short-term acute care hospitals, the
pathogens causing infections, and the
quality of antimicrobial drug
prescribing.
Today more than 5,000 short-term
acute care hospitals participate in
national HAI surveillance through the
CDC’s National Healthcare Safety
Network (NHSN, OMB Control No.
0920–0666, expiration 12/31/18). These
hospitals’ surveillance efforts are
focused on those HAIs that are required
to be reported as part of state legislative
mandates or Centers for Medicare &
Medicaid Services (CMS) Inpatient
Quality Reporting (IQR) Program.
Hospitals do not report data on all types
of HAIs occurring hospital-wide. Data
from a previous prevalence survey
showed that approximately 28% of all
HAIs are included in the CMS IQR
Program. Periodic assessments of the
magnitude and types of HAIs occurring
in all patient populations in hospitals
are needed to inform decisions by local
and national policy makers and by
hospital infection prevention
professionals regarding appropriate
targets and strategies for HAI
prevention.
The CDC’s hospital prevalence survey
efforts began in 2008–2009. A pilot
survey was conducted over a 1-day
period at each of nine acute care
hospitals in one U.S. city. This pilot
phase was followed in 2010 by a phase
2, limited roll-out HAI and
antimicrobial use prevalence survey,
conducted in 22 hospitals across 10
Emerging Infections Program sites
(California, Colorado, Connecticut,
Georgia, Maryland, Minnesota, New
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
58513
Mexico, New York, Oregon, and
Tennessee). A full-scale, phase 3 survey
was conducted in 2011, involving 183
hospitals in the 10 EIP sites. Data from
this survey conducted in 2011 showed
that there were an estimated 722,000
HAIs in U.S acute care hospitals in
2011, and about half of the 11,282
patients included in the survey in 2011
were receiving antimicrobial drugs. The
survey was repeated in 2015–2016 to
update the national HAI and
antimicrobial drug use burden; data
from this survey will also provide
baseline information on the quality of
antimicrobial drug prescribing for
selected, common clinical conditions in
hospitals. Data collection is ongoing at
this time.
A revision of the prevalence survey’s
existing OMB approval is sought to
reduce the data collection burden and to
extend the approval to allow another
short-term acute care hospital survey to
be conducted in 2019. Data from the
2019 survey will be used to evaluate
progress in eliminating HAIs and
improving antimicrobial drug use.
The 2019 survey will be performed in
a sample of up to 300 acute care
hospitals, drawn from the acute care
hospital populations in each of the 10
EIP sites (and including participation
from many hospitals that participated in
prior phases of the survey). Infection
prevention personnel in participating
hospitals and EIP site personnel will
collect demographic and clinical data
from the medical records of a sample of
eligible patients in their hospitals on a
single day in 2019, to identify CDCdefined HAIs and collect information on
antimicrobial drug use. The survey data
will be used to estimate the prevalence
of HAIs and antimicrobial drug use and
describe the distribution of infection
types and pathogens. The data will also
be used to determine the quality of
antimicrobial drug prescribing. These
data will inform strategies to reduce and
eliminate healthcare-associated
infections—a DHHS Healthy People
2020 objective (https://
www.healthypeople.gov/2020/
topicsobjectives2020/
overview.aspx?topicid=17). This survey
project also supports the CDC Winnable
Battle goal of improving national
surveillance for healthcare-associated
infections (https://www.cdc.gov/
winnablebattles/Goals.html) and the
CARB National Strategy (https://
www.whitehouse.gov/sites/default/files/
docs/carb_national_strategy.pdf) and
Action Plan (https://
www.whitehouse.gov/sites/default/files/
docs/national_action_
plan_for_combating_antibotic-resistant_
bacteria.pdf).
E:\FR\FM\25AUN1.SGM
25AUN1
58514
Federal Register / Vol. 81, No. 165 / Thursday, August 25, 2016 / Notices
There are no costs to the respondents
other than their time. The total
estimated annual burden hours is 1,860.
This represents a reduction in the total
estimated annual burden hours from the
previous approval due to a reduction in
the number of respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form Name
Infection Preventionist .....................................
Infection Preventionist .....................................
Healthcare Facility Assessment (HFA) ..........
Patient Information Form (PIF) ......................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–20366 Filed 8–24–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Statement of Organization, Functions,
and Delegations of Authority
Administration for Children
and Families, HHS.
AGENCY:
ACTION:
Notice.
Statement of Organization,
Functions, and Delegations of
Authority.
The Administration for Children and
Families (ACF) has realigned the Office
of Community Services (OCS). This
notice announces the realignment of
OCS functions to rename the Division of
State Assistance to the Division of
Community Assistance and establishes
the Division of Social Services. It also
consolidates the Division of Community
Discretionary Programs and the Division
of Community Demonstration Programs
to establish the Division of Community
Discretionary and Demonstration
Programs.
SUMMARY:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Jeannie Chaffin, Director, Office of
Community Services, 330 C Street SW.,
Washington, DC 20201, (202) 401–9333.
This notice amends Part K of the
Statement of Organization, Functions,
and Delegations of Authority of the
Department of Health and Human
Services (DHHS), Administration for
Children and Families (ACF), as
follows: Office of Community Services
(OCS), as last amended by 767 FR
67198, November 4, 2002, the changes
are as follows:
VerDate Sep<11>2014
19:30 Aug 24, 2016
Jkt 238001
I. Under Chapter KG, Office of
Community Services, delete KG in its
entirety and replace with the following:
KG.00 Mission. The Office of
Community Services (OCS) advises the
Secretary, through the Assistant
Secretary for Children and Families, on
matters relating to community programs
to promote economic self-sufficiency.
OCS is responsible for administering
programs that serve low-income and
needy individuals and address the
overall goal of economic security for
individuals and families with low
incomes and community improvement
for distressed neighborhoods. OCS
administers the Community Services
Block Grant, Social Services Block
Grant, and the Low Income Home
Energy Assistance Block Grant
programs. OCS also administers a
variety of discretionary grant programs
that foster family stability, economic
security, responsibility and self-support,
promote and provide services to
homeless and individuals with lowincome and develop new and
innovative approaches to reduce the
need for public assistance.
KG.10 Organization. The Office of
Community Services is headed by a
Director who reports directly to the
Assistant Secretary for Children and
Families. The office is organized as
follows:
Office of the Director (KGA)
Division of Community Assistance
(KGB)
Division of Energy Assistance (KGE)
Division of Community Discretionary
and Demonstration Programs (KGG)
Division of Social Services (KGH)
KG.20 Functions. A. Office of the
Director provides executive direction
and leadership to the Office of
Community Services (OCS) and
coordinates all elements of the Office.
The Deputy Director assists the Director
in carrying out the responsibilities of
the Office. Within the Office, the
administrative staff assists the Director
in managing the formulation and
execution of program and salaries and
expenses budgets, and in providing
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
100
100
Number of
responses per
respondent
1
63
Average
burden per
response
(in hrs.)
45/60
17/60
administrative, personnel and data
processing support services.
B. Division of Energy Assistance
administers the Low Income Home
Energy Assistance program (LIHEAP) at
the federal level. It develops guidelines,
policies and regulations to provide
direction to states, territories, Indian
tribes and tribal organizations in
administering LIHEAP. The Division of
LIHEAP calculates state allotments and
develops statistical information
regarding state plan characteristics,
energy consumption, state median
income estimates, fuel costs, and
housing and demographic
characteristics. It prepares, analyzes and
recommends specific proposals for new
legislation; prepares reports as required
by Congress; and identifies and
develops research and evaluation
priorities and assesses the impact of
research and evaluation findings and
statistical data in terms of program
directions.
The Division of LIHEAP provides
leadership in interpretation and
application of federal program policy as
it relates to compliance activities. The
Division of LIHEAP reviews grantee
applications and amendments; provides
the Office of Administration, Division of
Mandatory Grants with information
necessary to issue grants; and
investigates complaints. It provides
assistance to states, tribes and territories
in developing energy program policies
and operational procedures; evaluates
compliance of state and tribal policies
and operations with statutory and
regulatory requirements; and provides
support in developing and
implementing program improvements.
The Division of LIHEAP assists states
and other public and private
organizations by providing training and
technical assistance in areas related to
home energy consumption.
C. Division of Community Assistance
administers the Community Services
Block Grant (CSBG). It is responsible for
developing, updating and implementing
E:\FR\FM\25AUN1.SGM
25AUN1
]]>Agencies
[Federal Register Volume 81, Number 165 (Thursday, August 25, 2016)]
[Notices]
[Pages 58513-58514]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-20366]
[[Page 58513]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-16-0852]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Prevalence Survey of Healthcare-Associated Infections (HAIs) and
Antimicrobial Use in U.S. Acute Care Hospitals (OMB Control No. 0920-
0852, Expires 12/31/2016)--Revision--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Preventing healthcare-associated infections (HAIs) and reducing the
emergence and spread of antimicrobial resistance are priorities for the
CDC and the U.S. Department of Health and Human Services (DHHS).
Improving antimicrobial drug prescribing in the United States is a
critical component of strategies to reduce antimicrobial resistance,
and is a key component of the President's National Strategy for
Combating Antibiotic Resistant Bacteria (CARB), which calls for
``inappropriate inpatient antibiotic use for monitored conditions/
agents'' to be ``reduced 20% from 2014 levels'' (page 9, https://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf). To achieve these goals and improve patient
safety in the United States, it is necessary to know the current burden
of infections and antimicrobial drug use in different healthcare
settings, including the types of infections and drugs used in short-
term acute care hospitals, the pathogens causing infections, and the
quality of antimicrobial drug prescribing.
Today more than 5,000 short-term acute care hospitals participate
in national HAI surveillance through the CDC's National Healthcare
Safety Network (NHSN, OMB Control No. 0920-0666, expiration 12/31/18).
These hospitals' surveillance efforts are focused on those HAIs that
are required to be reported as part of state legislative mandates or
Centers for Medicare & Medicaid Services (CMS) Inpatient Quality
Reporting (IQR) Program. Hospitals do not report data on all types of
HAIs occurring hospital-wide. Data from a previous prevalence survey
showed that approximately 28% of all HAIs are included in the CMS IQR
Program. Periodic assessments of the magnitude and types of HAIs
occurring in all patient populations in hospitals are needed to inform
decisions by local and national policy makers and by hospital infection
prevention professionals regarding appropriate targets and strategies
for HAI prevention.
The CDC's hospital prevalence survey efforts began in 2008-2009. A
pilot survey was conducted over a 1-day period at each of nine acute
care hospitals in one U.S. city. This pilot phase was followed in 2010
by a phase 2, limited roll-out HAI and antimicrobial use prevalence
survey, conducted in 22 hospitals across 10 Emerging Infections Program
sites (California, Colorado, Connecticut, Georgia, Maryland, Minnesota,
New Mexico, New York, Oregon, and Tennessee). A full-scale, phase 3
survey was conducted in 2011, involving 183 hospitals in the 10 EIP
sites. Data from this survey conducted in 2011 showed that there were
an estimated 722,000 HAIs in U.S acute care hospitals in 2011, and
about half of the 11,282 patients included in the survey in 2011 were
receiving antimicrobial drugs. The survey was repeated in 2015-2016 to
update the national HAI and antimicrobial drug use burden; data from
this survey will also provide baseline information on the quality of
antimicrobial drug prescribing for selected, common clinical conditions
in hospitals. Data collection is ongoing at this time.
A revision of the prevalence survey's existing OMB approval is
sought to reduce the data collection burden and to extend the approval
to allow another short-term acute care hospital survey to be conducted
in 2019. Data from the 2019 survey will be used to evaluate progress in
eliminating HAIs and improving antimicrobial drug use.
The 2019 survey will be performed in a sample of up to 300 acute
care hospitals, drawn from the acute care hospital populations in each
of the 10 EIP sites (and including participation from many hospitals
that participated in prior phases of the survey). Infection prevention
personnel in participating hospitals and EIP site personnel will
collect demographic and clinical data from the medical records of a
sample of eligible patients in their hospitals on a single day in 2019,
to identify CDC-defined HAIs and collect information on antimicrobial
drug use. The survey data will be used to estimate the prevalence of
HAIs and antimicrobial drug use and describe the distribution of
infection types and pathogens. The data will also be used to determine
the quality of antimicrobial drug prescribing. These data will inform
strategies to reduce and eliminate healthcare-associated infections--a
DHHS Healthy People 2020 objective (https://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=17). This survey project
also supports the CDC Winnable Battle goal of improving national
surveillance for healthcare-associated infections (https://www.cdc.gov/winnablebattles/Goals.html) and the CARB National Strategy (https://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf)
and Action Plan (https://www.whitehouse.gov/sites/default/files/docs/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf).
[[Page 58514]]
There are no costs to the respondents other than their time. The
total estimated annual burden hours is 1,860. This represents a
reduction in the total estimated annual burden hours from the previous
approval due to a reduction in the number of respondents.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form Name respondents responses per response (in
respondent hrs.)
----------------------------------------------------------------------------------------------------------------
Infection Preventionist............... Healthcare Facility 100 1 45/60
Assessment (HFA).
Infection Preventionist............... Patient Information Form 100 63 17/60
(PIF).
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-20366 Filed 8-24-16; 8:45 am]
BILLING CODE 4163-18-P
